(1991). A polyadenylate binding protein localized to the granules of cytolytic induces DNA fragmentation in target cells. Cell
(1994). An immunohistochemical study of extracellular matrix in oral squamous cell carcinoma and its association with invasive and metastatic potential. Virchows Arch
(2000). Aspirin inhibitors tumor cell invasiveness induced by Epstein-Barr virus latent membrane protein 1 through suppression of matrix metalloproteinase-9 expression. Cancer Res
(2000). ES: Aggressive NK cell lymphoma insights in to the spectrum of NK cell derived malignancies. Histopathology
(1998). ES: Cytotoxic granular protein expression, Epstein-Barr virus strain type, and latent membrane protein-1 oncogene deletions in nasal T-lymphocyte/ natural killer cell lymphomas from Mexico. Mod Pathol
(1994). ES: High grade AIL and Epstein-Barr virus infection in 22 cases from Mexico. Mod Pathol
(1993). ES: Nasal lymphomas in Peru, high incidence of T-cell immunophenotype and Epstein-Barr virus infection.
(2005). ES: The pathology of NK-cell lymphomas and leukemias. Adv Anat Pathol
(1995). et al.: Clinicopathologic study of CD 56 (NCAM)-positive angiocentric lymphoma occurring in sites other than the upper and lower respiratory tract.
(2002). Expression of matrix metalloproteinase 1, matrix metalloproteinase 2, and metalloproteinase 9 in carcinoma of the head and neck. Correlation with p53 status, inductible nitric oxide synthase activity, and angiogenesis. Cancer
(1988). F: Lethal midline granuloma (polymorphic reticulosis) and lymphomatoid granulomatosis: evidence for monoclonal T-cell lymphoproliferative disorder. Cancer
(2001). F: p53 mutations in nasal natural killer/cell lymphoma from Mexico. Association with large cell morphology and advanced disease.
(1995). Guillem JG: Elevated tissue inhibitor of metalloproteinase 1 RNA in colorectal cancer stroma correlates with lymph nodes and distant metastasis. Clin Cancer Res
(1996). HA: Primary lymphoma of the nose including a relationship of lethal midline granuloma.
(1996). Ho FCS: Report of the workshop on nasal an related extranodal angiocentric T/natural killer cell lymphomas. Definitions, differential diagnosis, and epidemiology.
(1989). I: Nation-wide study of lethal midline granuloma in japan: frequencies of Wegener's granulomatosis, polymorphic reticulosis, malignant lymphoma and other related conditions.
(1985). Ishi Y: Tcell lymphoma: characterization by monoclonal antibodies. Ann Otol Rhinol Laryngol
(1999). Janowska-Wieczorek A: Interleukin-6 regulation of matrix metalloproteinase (MMP-2 and MMP-9) and tissue inhibitor of metalloproteinase (TIMP-1) expression in malignant non-Hodgkin's lymphomas. Blood
(1984). Khoo RKK: Features of malignant lymphomas in 294 Hong Kong Chinese patients, retrospective study covering an eight year period.
(2004). López-Otín C: Matriz metalloproteinases in cancer: from new functions to improved inhibition strategies.
(1996). LS: A n a l y s i s o f E p s t e i n - B a r r g e ne polymorphisms in normal donors and in virus-associated tumors from different geographic locations. Blood
(1998). Pagano JS: The expression of matrix metalloproteinase 9 is enhanced by Epstein-Barr virus latent membrane protein1. Proc Natl Acad Sci USA
(1984). Pathologic and clinical spectrum of post-thymic Tcell malignancies. Cancer Investigation
(1999). Shirasuna K: Expression of MMPs, MT-MMP, and TIMPs in squamous cell carcinoma of the oral cavity: correlations with tumor invasion and metastasis. Head Neck
(2000). Sinonasal T/NK cell lymphomas in the United States. Am J Surg Pathol
Stetler-Stevenson WG: Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in reactive and neoplastic lymphoid cells.